Oterus Biosystems, Inc.

About Oterus Biosystems, Inc.

𝗠𝗼𝗱𝗲𝗿𝗻𝗶𝘇𝗶𝗻𝗴 𝘁𝗵𝗲 "𝗕𝗹𝗮𝗰𝗸 𝗕𝗼𝘅" 𝗼𝗳 𝗜𝗩𝗙 | 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗮𝗽 𝗕𝗲𝘁𝘄𝗲𝗲𝗻 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗖𝘂𝗹𝘁𝘂𝗿𝗲 𝗮𝗻𝗱 𝗦𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝗶𝗲𝘀. 𝗔𝗯𝗼𝘂𝘁 At Oterus Biosystems, we believe starting a family is a fundamental human right. Yet for millions, IVF remains a "black box" of unpredictability and high costs. We are on a mission to change that. Oterus is modernizing the IVF lab by replacing static incubation with a first-of-its-kind Dynamic Embryo Culturing Platform. Our technology replicates the human reproductive tract, addressing two key failure points: embryo quality and implantation success. 𝗢𝘂𝗿 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 & 𝗜𝗺𝗽𝗮𝗰𝘁 Originally founded to solve uterine receptivity, we have pivoted to a "Tool-First" strategy focused on the Embryo Culturing Platform. This serves as a high-fidelity validation bridge, ensuring embryos are nurtured and "primed" for successful implantation. 𝗞𝗲𝘆 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲𝘀: Scientific Leadership: Led by CSO Lesley Blankenship-Williams, PhD, an expert embryologist bridging hardware engineering and reproductive biology. Technical Validation: Completed coast-to-coast shipping studies and mouse-to-human validation programs. Clinical Progress: Secured IRB approval for human embryo testing; establishing pilot interest with leading U.S. clinics and universities. Regulatory Roadmap: Finalized Class II (510k) medical device strategy in partnership with Beanstock Ventures. 𝗢𝘂𝗿 𝗩𝗶𝘀𝗶𝗼𝗻 We are building a standard of care that makes IVF predictable, affordable, and accessible to everyone. By providing embryos the environment they deserve, we ensure more families reach their "Day One." 𝗙𝗼𝗰𝘂𝘀 𝗔𝗿𝗲𝗮𝘀: ART, IVF Innovation, Embryology, Microfluidics, Medical Device, Maternal-Fetal Health. 𝗩𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁: [www.oterusbio.com]